Evropská unie - finština - EMA (European Medicines Agency)

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - rokotteet - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. käyttö tämä rokote tulee virallisten suositusten mukaisesti.

Finsko - finština - Fimea (Suomen lääkevirasto)

stada arzneimittel ag - lisinoprilum dihydricum - tabletti - 2.5 mg - lisinopriili

Finsko - finština - Fimea (Suomen lääkevirasto)

les laboratoires servier - amlodipine besylate, perindopril arginine - tabletti - 5 mg / 5 mg - perindopriili ja amlodipiini

Finsko - finština - Fimea (Suomen lääkevirasto)

les laboratoires servier - perindopril arginine, amlodipine besylate - tabletti - 5 mg / 10 mg - perindopriili ja amlodipiini

Finsko - finština - Fimea (Suomen lääkevirasto)

les laboratoires servier - perindopril arginine, amlodipine besylate - tabletti - 10 mg / 5 mg - perindopriili ja amlodipiini

Finsko - finština - Fimea (Suomen lääkevirasto)

les laboratoires servier - perindopril arginine, amlodipine besylate - tabletti - 10 mg / 10 mg - perindopriili ja amlodipiini

Finsko - finština - Fimea (Suomen lääkevirasto)

b. braun melsungen ag - ropivacaine hydrochloride monohydrate - injektio-/infuusioneste, liuos - 2 mg/ml - ropivakaiini

Finsko - finština - Fimea (Suomen lääkevirasto)

b. braun melsungen ag - ropivacaine hydrochloride monohydrate - injektioneste, liuos - 5 mg/ml - ropivakaiini

Finsko - finština - Fimea (Suomen lääkevirasto)

b. braun melsungen ag - ropivacaine hydrochloride monohydrate - injektioneste, liuos - 7.5 mg/ml - ropivakaiini

Finsko - finština - Fimea (Suomen lääkevirasto)

b. braun melsungen ag - ropivacaine hydrochloride monohydrate - injektioneste, liuos - 10 mg/ml - ropivakaiini